GlassScriptPhysician profile
Megan K Loo
NPI 1477076131
$35,593.71
in general payments reported to CMS, 2019-2025
22 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $401 · 2021: $4,352 · 2022: $3,641 · 2023: $3,386 · 2024: $7,100 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,756 · Travel and Lodging: $4,165 · Consulting Fee: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,747.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,756.25 |
| Travel and Lodging | $4,164.60 |
| Consulting Fee | $430.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,793.76 | 2021-2025 | Corevalve Evolut R, Vitalflow Console, Penditure |
| Edwards Lifesciences Corporation | $7,313.59 | 2020-2025 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abiomed | $7,265.61 | 2022-2025 | Impella |
| Atricure, INC. | $2,352.54 | 2019-2025 | Synergy Ablation System |
| Abbott Laboratories | $1,895.47 | 2019-2025 | Navitor, Mitraclip, Epic |
| Intuitive Surgical, INC. | $1,567.45 | 2021 | |
| Baxter Healthcare | $1,358.53 | 2019-2025 | Floseal, Preveleak, Perclot |
| Livanova USA, INC. | $287.21 | 2023 | Protekduo, Tandemlife |
| Ethicon US, LLC | $250.06 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $246.79 | 2019-2022 | |
| Shockwave Medical, INC | $246.63 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Davol INC. | $222.59 | 2022-2023 | Progel Applicator Spray Tips |
| Stryker Corporation | $179.96 | 2021-2022 | |
| Inari Medical, INC. | $154.03 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $132.13 | 2023-2025 | Watchman Flx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $124.83 | 2019 | |
| Bolton Medical INC | $51.59 | 2022 | |
| Cardiva Medical, INC. | $46.09 | 2024-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Dilon Technologies, INC. | $40.65 | 2023 | Hemoblast Bellows |
| Lsi Solutions INC | $26.75 | 2024 | Cor-Knot |
| Artivion, INC. | $23.76 | 2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cardiac Non-Synergraft |
| Merck Sharp & Dohme LLC | $13.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Loo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.